About the Speaker

Speaker 1

He Miao
Sinopharma
China

China National Pharmaceutical Group Corporation (Sinopharm) is the largest medical and healthcare group under the direct leadership of the State-owed Assets Supervision and Administration Commission of the State Council. It is famous for its most comprehensive competitiveness and complete chain of the whole pharmaceutical industry in China. The total sales revenue of Sinopharm Group is over 350 billion RMB in 2017. It ranks 194th in the "Fortune Global 500". Sinopharm Fortune Way Company (Sinopharm Fortune Way) is wholly-owned subsidiary of Sinopharm. The company shoulders Sinopharm´s strategic mission of developing international pharmaceutical business, and medical and healthcare industry. According to International Trading Business, Sinopharm develop Medical Products, Medical Equipment and Facilities, and Healthy Food Raw Materials aspects. Main products of Healthy Food Raw Materials indicate sunflower seed oil, peanut oil, non-gmo rapeseed oil, non-gmo soybean oil peanuts, sesame seeds, green mung beans and tree nuts. As China´s main importer of sunflower seed oil, the company is actively engaged in the import of high and medium level edible oil, milk powder, coffee beans and other healthy food raw materials. The company has formed strategic partnerships with China´s well-known edible oil and healthy food companies and established a complete market supply system of healthy food raw materials. In recent years, the peanuts, peanut oil and sesame seeds business reaches India, America, Argentina, Brazil, Senegal, Sudan, Ethiopia and etc. countries with excellent reputation and brand image in international trade.
HE graduated from University of London and obtained a master´s degree in 2012. He had been a Product Manager in Sinopharm Fortune Way Company for 6 years, developing purchase and sales for peanut and peanut oil business.